[-] Show simple item record

dc.contributor.authorSkladzien, Stephanieeng
dc.contributor.authorDresang, Lee T.eng
dc.date.issued2010-10eng
dc.description.abstractSupplementation with intramuscular 17-alpha hydroxyprogesterone caproate (17P) significantly reduces the incidence of preterm delivery for women at increased risk of preterm birth. All women with a singleton pregnancy and a history of prior preterm birth should be offered weekly injections. Additional studies are needed to investigate use in women with a short cervix, multiple gestations, and in arrest of preterm labor. Complete maternal and fetal safety profiles, as well as ideal dose, route of administration, and duration of treatment, are also evolving.eng
dc.identifier.citationEvidence Based Practice 13(10): 11.eng
dc.identifier.urihttp://hdl.handle.net/10355/9448eng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofEvidence Based Practice 13(10): 11.eng
dc.relation.ispartofcollectionEvidence Based Practice, 2010eng
dc.subjectdelivery rateseng
dc.subjectprogesterone therapyeng
dc.subject.lcshLabor (Obstetrics)eng
dc.subject.lcshDelivery (Obstetrics)eng
dc.subject.lcshProgesteroneeng
dc.title17-Alpha hydroxyprogesterone for reducing preterm laboreng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record